Background/Aims: We aimed to determine the association between the co-expression patterns of Notch1, Snail, and p53 proteins (NSP) and the postoperative prognosis of hepatocellular carcinoma (HCC). Methods: The immunoblot data for molecular expression (147 HCC/corresponding non-HCC tissues and 15 dysplastic nodules) and the sequencing data for p53 mutations (110 HCCs) were obtained from our previous study. Data analyses were restricted to cases with HCC differentiation grade III (n=47), due to its high p53 mutation rate. Results: Nineteen of the 47 patients (40.4%) -comprising 12 in the liver and 7 in distant organs-had relapsed at 1-2 years after surgery. There was no relationship between p53 mutation and postoperative recurrence in the grade III HCCs. Seven (87.5%) of the eight relapsed cases with Notch1, Snail, and p53 (wild) co-expression experienced recurrence only within the liver, and all tumors were smaller than 5 cm in diameter. Extrahepatic relapse occurred mostly in HCC patients with tumors larger than 5 cm in diameter, without any deviation in the NSP pattern. Conclusions: The results of this preliminary study suggest that the co-expression of Notch1, Snail, and p53 (wild) is not inferior to the patterns with p53 mutation as an indicator of postoperative recurrence of grade III HCC. (Korean J Hepatol 2012;18:63-74)
INTRODUCTION
They include tumor size and number, microvascular invasion, portal vein tumor thrombosis, the presence of satellite nodules, differentiation grade of the tumor cells, and the encapsulation state. [4] [5] [6] Tumor size (usually greater than 5 cm), multiplicity, a cut margin narrower than 1 cm, and tumor stage (including vascular invasion) are independent factors associated with early (within 2 years) recurrence after surgical resection. 3, 4 The preoperative hepatic functional reserve and microscopic vascular invasion can enhance early recurrence of small HCCs. 7 Early multinodular recurrence after surgical resection is not unusual in HCCs with multiple tumor nodules and portal vein thrombi. 3 Furthermore, late recurrence (>2 years after resection) is significantly associated with Ishak hepatic inflammatory activity >6; indocyanine green (ICG) retention rate at 15 min (ICG-15) >10%; and hepatitis B virus (HBV) DNA level >10 6 copies/mL. 4 Alpha-fetoprotein (AFP) and Lens culinaris agglutinin-reactive AFP (AFP-L3) are serological biomarkers of HCC with a more malignant nature. 6 Multiple intrahepatic or extrahepatic metastases are associated with poor prognosis after recurrence. 8 Reportedly, the proportions of intra-and extrahepatic recurrences of HCC following surgery are 80% and 20%, respectively. 9 In brief, the organs involved in extrahepatic recurrence are lung (10.4-12.6%), adrenal glands (11%), peritoneum (6%), pancreas (3%), bone (1.5%), and brain (1.5%). [9] [10] [11] Given the increasing chances of earlier diagnosis by an HCC screening program for high-risk individuals selected from patients with chronic liver diseases, it is critical to identify the characteristic patterns of molecules that are associated with HCC recurrence and the preferred organ sites of relapse after surgical treatment. Candidate molecules associated with prognosis or risk of recurrence include osteopontin 9 and stathmin 12 in relation with intrahepatic recurrence of HCCs, the acquisition of p53 mutation (p53Mut) as a poor prognostic molecular marker, 13 
MATERIALS AND METHODS
Inclusion of patients with immunoblot data for Notch1, Snail, and p53 and data for p53 mutations in HCCs
For this study, we obtained 162 immunoblots for the expression of Notch1, Snail, and p53 proteins and 110 sequences for p53 mutations in HCCs. All experiments were performed as described in the previous study. 15 Briefly, rabbit monoclonal anti-Notch1 (diluted 1:100, Cell Signaling, Danvers, MA), rabbit polyclonal anti-Snail (diluted 1:100, Abcam, Cambridge, MA), and mouse monoclonal anti-p53 (diluted 1:100, Santa Cruz Biotechnology) antibodies were used to detect each protein in paraffin sections, and automated sequencing was performed to detect p53 mutations in frozen tissues (Appendix Fig. 1 Table 2 ). evaluation, we kept a routine histological examination data file on differentiation grades, tumor size, tumor capsule formation (encapsulation), capsular infiltration, microvascular invasion, portal vein invasion, and satellite nodules.
Differentiation was graded according to Edmondson and
Steiner's criteria. 18 Informed consent was obtained from each patient, and tissue collection was approved by the Institutional Review Board.
Statistical analysis
Statistical analysis was performed using R statistics 
RESULTS

Association of grade III HCC with pathological features indicating the risk of postoperative recurrence
Because HCCs are classified on the basis of cellular morphology, differentiation grades do not directly depict the Table 2 . Summary of the distribution of p53 mutations, recurrence frequencies, and relapse sites according to the NSP pattern in grade III HCC Table 1 ). This observation strongly suggests that the coexpression of these 3 core molecules may be regulated differently according to the differentiation grade of HCC.
Association of the p53 mutation rate with NSP patterns according to differentiation grades
In our previous study, we demonstrated that both the expression level and the mutation of p53 protein were key factors regulating the nature of co-expression of the 3 core molecules selected for this study. 15 Although there was a positive correlation between differentiation grade and the total incidence of p53 upregulation by immunoblot analysis, the incidence of upregulation of wild-type p53 was not altered in the various differentiation grades, whereas the majority of p53 mutations occurred in grade III HCC (Table   1 and Appendix Table 2 ).
In this study cohort with grade III HCC, the p53
Sun Kyung Jang, et al. NSP patterns in grade III HCC recurrence 67 occurred in NSP-IIA1 and 63.6% (7/11) in NSP-IIB, whereas 20% (3/15) occurred in NSP-IA1 (P<0.001) ( Table 2 ). The p53 mutation rate was different between the NSP-I and NSP-II categories.
Association of pathological features with NSP patterns according to differentiation grades
Of the pathological features associated with differentiation grades, tumor size, microvascular invasion, portal vein invasion, and satellite nodules did not differ according to the NSP pattern (Appendix Table 3 12.5% (1/8), respectively) (Appendix Table 5 ). Furthermore, both NSP-IA1 (Notch1↑/Snail↑/p53↑) and NSP-IIB patterns showed significant trends of capsular infiltration, compared to the NSP-IA2 (Notch1↑/Snail↑/p53↔) pattern with incidences of 50% (8/18), 53.3% (8/15), and 0% (0/6), respectively (P=0.002 and P=0.004, respectively) (Appendix Table 5 ). Data was not available in three cases. ↑, overexpression greater than a 2-fold increase; DFI, disease-free interval. differences in clinical variables, including age, sex, and preoperative serum AFP and PIVKA-II levels between the recurrent and non-recurrent groups (Table 3) . In this cohort, only portal vein invasion was significantly correlated with recurrence (P=0.003): 42.1% (8/19) in the recurrence and 7.1% (2/28) in the non-recurrence groups (Table 3 ). These data suggest that, when limited to grade III HCC, portal vein invasion is the most important pathological feature for predicting the risk of postoperative recurrence.
Characteristic pathological features related to postoperative recurrence of grade III HCC
Association of the NSP pattern with postoperative recurrence in grade III HCC
The individual expression status of Notch1, Snail, and p53 proteins was not associated with recurrence. Moreover, p53 mutation was not a significant prognostic factor for postoperative recurrence when the analysis was restricted to the grade III HCC group (Table 3 ). In addition, the recurrence rates of the NSP-IA1 (Notch1↑/Snail↑/p53↑) with p53 wild dominant and NSP-IIB (Notch1↔/Snail↔ /p53↑) with p53 mutant dominant were 53.3% (8/15) and 18.2% (2/11), respectively (P=0.1092) ( Table 2 ).
In HCCs with the NSP-I pattern, the mean tumor size was not significantly different between the recurrence and non-recurrence groups (smaller than 5 cm in both groups).
However, in HCCs with the NSP-IIA1 and NSP-IIB patterns, the mean tumor size was significantly larger in the recurrence group than in the non-recurrence group (Table 2) .
Other pathological prognostic features were not significantly different between the recurrence and non-recurrence groups according to the NSP patterns.
Characteristic pathological features associated with the relapse sites of grade III HCC Twelve of 19 cases (63.2%) recurred within the liver and 7 (36.8%) recurred at extrahepatic sites, including 6 lung and 1 mediastinal lymph node metastases (Appendix Table   1 ). Two of 6 cases of pulmonary recurrence were accompanied by metastasis in other sites: 1 in the brain and 1 in an abdominal lymph node. There were no significant differences between the intrahepatic and extrahepatic ↑, overexpression greater than a 2-fold increase; ↔, no overexpression; NSP patterns, co-expression patterns of Notch1, Snail and p53 proteins; Number of cases in each differentiation grade were 33 in grade I, 40 in grade II and 74 in grade III, respectively; '-', no cases or not statistically significant (P>0.1); Chi-square test with Yates' continuity correction was used to compare the difference.
